Fibator Ez Tablet

Fibator Ez Tablet is a triple-action lipid-lowering medicine formulated to effectively reduce high cholesterol and triglyceride levels in the blood. It combines three scientifically proven agents — Atorvastatin, Ezetimibe, and Fenofibrate — that work together to provide comprehensive lipid management and prevent cardiovascular diseases such as heart attack, stroke, and atherosclerosis.

• Atorvastatin (10 MG): A statin that inhibits HMG-CoA reductase, reducing the liver’s production of LDL (“bad” cholesterol) and triglycerides while raising HDL (“good” cholesterol”).

• Ezetimibe (10 MG): Reduces cholesterol absorption from the intestine, lowering the total cholesterol entering the bloodstream.

• Fenofibrate (160 MG): Primarily reduces elevated triglycerides and VLDL levels, improving lipid metabolism and protecting against plaque buildup.

Together, these three agents address all components of dyslipidemia — high LDL, low HDL, and elevated triglycerides — making the combination especially beneficial for patients with mixed hyperlipidemia, metabolic syndrome, obesity, or diabetes-related lipid disorders.